NovoCure Limited Announces Launch of Initial Public Offering

ST. HELIER, Jersey–(BUSINESS WIRE)–NovoCure Limited, a commercial stage oncology company pioneering a novel therapy for solid tumors, announced today the launch of its initial public offering of 12,500,000 shares of its common stock, including 7,500,000 shares to be sold by NovoCure Limited and 5,000,000 shares to be sold by selling shareholders. The initial public offer is currently expected to be between $26 and $29 per share. The underwriters for the offering will also have a 30-day option

Source:: http://feeds.businesswire.com/click.phdo?i=2469f0568df266ce3297c9d471a753ef

Print Friendly, PDF & Email

Share This

Share this post with your friends!